Topics
Fibrosis and Cirrhosis
HBV
HCV
Hepatocellular Carcinoma
HIV Coinfection
Nash, ALD, etc.
Other Hepatitis Viruses
Transplantation
Conference Coverage
2018 Annual Meeting of the European Association for the Study of the Liver
2017 Annual Meeting of the American Association for the Study of Liver Diseases
2017 Annual Meeting of the European Association for the Study of the Liver
2016 Annual Meeting of the American Association for the Study of Liver Diseases
2016 Annual Meeting of the European Association for the Study of the Liver
More...
Education
Hepatitis C Update: A Growing Challenge With Evolving Management Solutions
Expert Insights in Selecting Therapy for Chronic Hepatitis B
A Call to Arms: Tools for HCV Treaters to Maximize HCV Cure Rates and Advance Toward HCV Elimination
Think You Know NASH? A Quiz-Based Challenge on Current and Emerging Management Strategies
What Strategies Can Specialists Use to Accelerate Toward HCV Elimination?
More...
ClinicalThought
HBV Infection: When to Treat vs When to Monitor?
How I Manage HCC Risk Following HCV Cure
Adopting Strategies to Eliminate HCV in Persons Who Inject Drugs
How New Data From AASLD 2017 Inform the Use of 8-Week Regimens for HCV
New Insights on NAFLD/NASH From AASLD 2017
More...
Decision Support
inPractice
Decision Support Tools
CCO Live Events
Slidesets & Resources
Audio
Cases
PDF
Slidesets
Video
Save Bookmark
Email to a Colleague
CCO Home
/
Hepatitis
/
Treatment Updates
/ AASLD HCC
Integrating Immunotherapy Into the Treatment of Hepatocellular Carcinoma: A Multidisciplinary Perspective
Table of Contents
AASLD HCC Slides
•
Immunotherapy for Cancer
•
Immune CPIs in HCC
•
Key Issues with Immunotherapy in HCC
AASLD HCC Webcast
•
HCC Immunotherapy
Program Overview
Integrating Immunotherapy Into the Treatment of Hepatocellular Carcinoma: A Multidisciplinary Perspective
Gain expert perspective on optimal use of promising new checkpoint inhibitors for patients with hepatocellular carcinoma through 3 downloadable PowerPoint slidesets and an on-demand Webcast from the live symposium presented at the 2016 annual meeting of the AASLD in Boston, Massachusetts.
Featured content
Overview of Immunotherapy for Cancer
In this downloadable slideset, Osama E. Rahma, MD, provides an overview of immunotherapy in cancer, including tumor immunology and evolution of immune checkpoint inhibitors in solid tumors, from a satellite symposium at the 2016 American Association for the Study of Liver Diseases Annual Meeting.
Date Posted: 11/11/2016
1
2
Latest Content
4 of 4 Shown
Integrating Immunotherapy Into the Treatment of Hepatocellular Carcinoma: A Multidisciplinary Perspective
Review the mechanism of action for immune checkpoint inhibitors, the rationale and data supporting their use in HCC, and key issues and controversies around moving this new class of agents into the clinic from the live satellite symposium at AASLD 2016.
Source:
Integrating Immunotherapy Into the Treatment of Hepatocellular Carcinoma: A Multidisciplinary Perspective
Date Posted:
12/5/2016
Clinical Development of Immune Checkpoint Inhibitors in HCC
In this downloadable slideset, Ghassan K. Abou-Alfa, MD, MBA, reviews the rationale for immunotherapy in hepatocellular carcinoma, as well as the emerging and ongoing data supporting the use of immune checkpoint inhibitors to treat patients with HCC, from a satellite symposium at the 2016 American Association for the Study of Liver Diseases Annual Meeting.
Source:
Integrating Immunotherapy Into the Treatment of Hepatocellular Carcinoma: A Multidisciplinary Perspective
Date Posted:
11/14/2016
Key Issues and Current Controversies in Moving Immunotherapy Into the Clinic for Patients With Advanced HCC
In this downloadable slideset, Andrew X. Zhu, MD, PhD, FACP, reviews the key issues around integrating immune checkpoint inhibitors into the clinic for patients with HCC, including management of immune-related adverse events, predictors of response, resistance, and safety concerns, from a satellite symposium at the 2016 American Association for the Study of Liver Diseases Annual Meeting.
Source:
Integrating Immunotherapy Into the Treatment of Hepatocellular Carcinoma: A Multidisciplinary Perspective
Date Posted:
11/11/2016
Overview of Immunotherapy for Cancer
In this downloadable slideset, Osama E. Rahma, MD, provides an overview of immunotherapy in cancer, including tumor immunology and evolution of immune checkpoint inhibitors in solid tumors, from a satellite symposium at the 2016 American Association for the Study of Liver Diseases Annual Meeting.
Source:
Integrating Immunotherapy Into the Treatment of Hepatocellular Carcinoma: A Multidisciplinary Perspective
Date Posted:
11/11/2016
4 of 4 Shown
Show 0 More
Loading...
Jointly provided by Postgraduate Institute for Medicine and Clinical Care Options, LLC
Contact Info
Supported by an educational grant from
Presented for attendees of the 67th AASLD Annual Meeting. This event/function is sponsored by Clinical Care Options, LLC and supported by Bristol-Myers Squibb. This is not an official function/event of the American Association for the Study of Liver Diseases